Consolidated Statements of Stockholders' Equity (Deficit) - USD ($) $ in Thousands		Total	Common Stock	Additional Paid-In Capital	Accumulated Deficit	Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Dec. 31, 2018			109,491,277
Beginning balance at Dec. 31, 2018		$ 2,831	$ 11	$ 887,289	$ (884,122)	$ (347)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation expense		707		707
Shares issued in connection with employee stock plans, net of shares withheld for employee taxes (in shares)			430,370
Shares issued in connection with employee stock plans, net of shares withheld for employee taxes		(53)		(53)
Assignment of NantHealth Labs (see Note 19)		20		20
Other comprehensive loss		55				55
Net income (loss)		(19,923)			(19,923)
Ending balance (in shares) at Mar. 31, 2019			109,921,647
Ending balance at Mar. 31, 2019		(16,363)	$ 11	887,963	(904,045)	(292)
Beginning balance (in shares) at Dec. 31, 2018			109,491,277
Beginning balance at Dec. 31, 2018		2,831	$ 11	887,289	(884,122)	(347)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Other comprehensive loss		137
Net income (loss)	[1]	(34,636)
Ending balance (in shares) at Jun. 30, 2019			110,454,507
Ending balance at Jun. 30, 2019		(30,496)	$ 11	888,461	(918,758)	(210)
Beginning balance (in shares) at Mar. 31, 2019			109,921,647
Beginning balance at Mar. 31, 2019		(16,363)	$ 11	887,963	(904,045)	(292)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation expense		707		707
Shares issued in connection with employee stock plans, net of shares withheld for employee taxes (in shares)			532,860
Shares issued in connection with employee stock plans, net of shares withheld for employee taxes		(209)	$ 0	(209)
Other comprehensive loss		82				82
Net income (loss)		(14,713)			(14,713)
Ending balance (in shares) at Jun. 30, 2019			110,454,507
Ending balance at Jun. 30, 2019		(30,496)	$ 11	888,461	(918,758)	(210)
Beginning balance (in shares) at Dec. 31, 2019			110,619,678
Beginning balance at Dec. 31, 2019		(57,136)	$ 11	889,955	(946,884)	(218)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation expense		668		668
Other comprehensive loss		(188)				(188)
Net income (loss)		23,065			23,065
Ending balance (in shares) at Mar. 31, 2020			110,619,678
Ending balance at Mar. 31, 2020		(33,591)	$ 11	890,623	(923,819)	(406)
Beginning balance (in shares) at Dec. 31, 2019			110,619,678
Beginning balance at Dec. 31, 2019		(57,136)	$ 11	889,955	(946,884)	(218)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Other comprehensive loss		(198)
Net income (loss)	[1]	(25,224)
Ending balance (in shares) at Jun. 30, 2020			110,929,357
Ending balance at Jun. 30, 2020		(82,221)	$ 11	890,292	(972,108)	(416)
Beginning balance (in shares) at Mar. 31, 2020			110,619,678
Beginning balance at Mar. 31, 2020		(33,591)	$ 11	890,623	(923,819)	(406)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation expense		408		408
Shares issued in connection with employee stock plans, net of shares withheld for employee taxes (in shares)			309,679
Shares issued in connection with employee stock plans, net of shares withheld for employee taxes		(739)		(739)
Other comprehensive loss		(10)				(10)
Net income (loss)		(48,289)			(48,289)
Ending balance (in shares) at Jun. 30, 2020			110,929,357
Ending balance at Jun. 30, 2020		$ (82,221)	$ 11	$ 890,292	$ (972,108)	$ (416)

[1] The statements for the six months ended June 30, 2020 and 2019 include the Connected Care Business (see Note 4).